Ghost Tree Capital as of Dec. 31, 2014
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 56 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences Call Option (GILD) | 8.6 | $18M | 190k | 94.26 | |
| Stryker Corporation Call Option (SYK) | 6.1 | $13M | 135k | 94.33 | |
| ISIS Pharmaceuticals Call Option | 5.9 | $12M | 200k | 61.74 | |
| Zimmer Holdings (ZBH) | 4.7 | $9.8M | 86k | 113.42 | |
| Avalanche Biotechnologies In | 3.2 | $6.8M | 125k | 54.00 | |
| Wright Medical | 3.0 | $6.3M | 235k | 26.87 | |
| Puma Biotechnology (PBYI) | 2.7 | $5.7M | 30k | 189.27 | |
| Flamel Technologies Sa Sponsored Adr | 2.7 | $5.6M | 325k | 17.13 | |
| Cepheid | 2.6 | $5.4M | 100k | 54.14 | |
| Alnylam Pharmaceuticals (ALNY) | 2.6 | $5.3M | 55k | 97.00 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 2.5 | $5.3M | 286k | 18.45 | |
| DepoMed | 2.3 | $4.8M | 300k | 16.11 | |
| Dyax | 2.2 | $4.6M | 325k | 14.06 | |
| Actavis SHS | 2.2 | $4.5M | 18k | 257.43 | |
| Zeltiq Aesthetics | 2.1 | $4.5M | 160k | 27.91 | |
| Nevro (NVRO) | 2.1 | $4.4M | 115k | 38.67 | |
| Ptc Therapeutics I (PTCT) | 2.1 | $4.4M | 85k | 51.76 | |
| Portola Pharmaceuticals | 2.0 | $4.2M | 150k | 28.32 | |
| NuVasive | 2.0 | $4.2M | 90k | 47.16 | |
| Insys Therapeutics Com New | 2.0 | $4.2M | 100k | 42.16 | |
| Horizon Pharma SHS | 1.9 | $3.9M | 300k | 12.89 | |
| Air Methods Corp Com Par $.06 | 1.8 | $3.7M | 85k | 44.04 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $3.6M | 40k | 90.40 | |
| Kite Pharma | 1.7 | $3.5M | 60k | 57.67 | |
| Salix Pharmaceuticals | 1.7 | $3.4M | 30k | 114.93 | |
| AMAG Pharmaceuticals | 1.6 | $3.4M | 80k | 42.62 | |
| Advaxis | 1.6 | $3.4M | 423k | 8.01 | |
| Universal Hlth Svcs CL B (UHS) | 1.6 | $3.3M | 30k | 111.27 | |
| Ophthotech | 1.4 | $2.9M | 65k | 44.88 | |
| Quidel Corporation | 1.4 | $2.9M | 100k | 28.92 | |
| Valeant Pharmaceuticals Int | 1.4 | $2.9M | 20k | 143.10 | |
| Therapeuticsmd | 1.4 | $2.8M | 637k | 4.45 | |
| Bluebird Bio (BLUE) | 1.3 | $2.8M | 30k | 91.73 | |
| Amicus Therapeutics (FOLD) | 1.2 | $2.5M | 300k | 8.32 | |
| Accuray Incorporated (ARAY) | 1.1 | $2.3M | 300k | 7.55 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 1.0 | $2.2M | 80k | 27.12 | |
| Intuitive Surgical Com New (ISRG) | 1.0 | $2.1M | 4.0k | 529.00 | |
| BioDelivery Sciences International | 1.0 | $2.1M | 175k | 12.02 | |
| Ariad Pharmaceuticals | 1.0 | $2.1M | 300k | 6.87 | |
| AtriCure (ATRC) | 1.0 | $2.0M | 100k | 19.96 | |
| Achillion Pharmaceuticals Call Option | 0.9 | $1.8M | 150k | 12.25 | |
| Immunogen Call | 0.9 | $1.8M | 300k | 6.10 | |
| Bellicum Pharma | 0.8 | $1.7M | 75k | 23.04 | |
| Raptor Pharmaceutical | 0.8 | $1.6M | 150k | 10.52 | |
| Merit Medical Systems (MMSI) | 0.6 | $1.3M | 75k | 17.33 | |
| Tandem Diabetes Care | 0.6 | $1.3M | 100k | 12.70 | |
| Nanostring Technologies (NSTGQ) | 0.6 | $1.3M | 90k | 13.93 | |
| Smith & Nephew Spdn Adr New (SNN) | 0.5 | $1.1M | 30k | 36.73 | |
| Auspex Pharmaceuticals | 0.5 | $1.1M | 20k | 52.50 | |
| Wright Med Group Right 03/01/2019 | 0.4 | $884k | 185k | 4.78 | |
| Ocera Therapeutics | 0.4 | $796k | 125k | 6.37 | |
| Biolase Technology | 0.4 | $789k | 300k | 2.63 | |
| Celladon | 0.4 | $781k | 40k | 19.52 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $743k | 250k | 2.97 | |
| Assembly Biosciences | 0.2 | $511k | 65k | 7.86 | |
| Globeimmune (GBIM) | 0.1 | $178k | 24k | 7.57 |
